Author

Canchai Yang

Michigan State UniversityORCID 0000-0002-0125-9298Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1

Frequent Co-Authors

Craig C. WelboniD· 2 shared Dohun PyeoniD· 2 shared Lexi VuiD· 2 shared M. I. KhaliliD· 2 shared William Charles SpanosiD· 2 shared Abigail Z. BennettiD· 1 shared Andrew J. OliveiD· 1 shared C. YiniD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Craig C. WelbonORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMar 18, 2026

ULK1 drives NDP52-mediated selective autophagic degradation of MHC-I to promote immune evasion in HPV-positive head and neck cancer

Lexi Vu, Nicholas S. Giacobbi, M. I. Khalil…·Dohun Pyeon

This study identifies ULK1-driven autophagy as a mechanism by which HPV+ HNC cells degrade MHC-I, promoting immune evasion and tumor growth.

DOI 10.64898/2026.03.14.711071

humanproteomics

Cancer BiologyProceedings of the National Academy of SciencesPeer-reviewedMar 9, 2026

The membrane-associated ubiquitin ligase MARCHF8 promotes cancer immune evasion by degrading MHC class I proteins

M. I. Khalil, Jie Wang, Lexi Vu…·Dohun Pyeon

This study identifies MARCHF8 as a driver of cancer immune evasion by degrading MHC-I proteins and shows its inhibition enhances antitumor immunity and response to immunotherapy.

4 citationstop 3%